A Phase III Multicenter Randomized Sham Controlled Study to Determine the

A Phase III Multicenter Randomized Sham Controlled Study to Determine the
99 years or below
All
Phase 2
1 Location

Brief description of study

A study that tests BI 1467335 in patients with diabetic eye disease (diabetic retinopathy). It looks at the way BI 1467335 is taken up, the effects it has, and how well it is tolerated.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: TBD, tbd, tbd
  • Age: 99 years or below
  • Gender: All
Updated on 27 Aug 2018. Study ID: 828398

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.